Cord Blood America announced today that its CEO, Matthew Schissler, was featured in an interview with Francis Gaskins at StreetIQ.com. The full interview can be heard at this link: StreetIQ Interview
In the interview, the CEO discussed Cord Blood’s recently reported financial results. For the six months ended June 30 of this year, the company announced $4.04 million in six month revenues and $1.4 million in gross profits, which the CEO was particularly pleased with as it will provide Cord Blood with additional working capital.
The interview also overviewed the company’s recent acquisition, history of growth, why CBAI.OB is undervalued, and the importance of umbilical cord blood stem cell storage.
Let us hear your thoughts: Cord Blood America Inc. Message Board